Physician profile
Gurpreet Singh
NPI 1184832305
$908.81
in general payments reported to CMS, 2019-2025
7 companies · $622 in 2025
The $622 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2022: $106 · 2023: $29.96 · 2024: $43.04 · 2025: $622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $695.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $390.04 | 2025 | Rezdiffra |
| Glaukos Corporation | $232.37 | 2025 | Photrexa Viscous and Photrexa |
| Intuitive Surgical, INC. | $107.52 | 2019 | |
| Merit Medical Systems INC | $86.00 | 2022 | |
| Abbvie INC. | $49.84 | 2022-2023 | Rinvoq |
| Takeda Pharmaceuticals U.S.A., INC. | $22.95 | 2024 | Entyvio |
| Janssen Biotech, INC. | $20.09 | 2024 | Stelara |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gurpreet Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.